Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Sekiguchi; Yoshinori
Address:
Tokyo, JP
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
8030499 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocy October 4, 2011
It is intended to provide a drug which is efficacious against pathological conditions relating to arginine-vasopressin V1b receptor. More particularly speaking, it is intended to provide a drug which has a therapeutic or preventive effect on depression, anxiety, Alzheimer's disease,
7601734 Cyclic amine compound October 13, 2009
An object of the present invention is to provide a cyclic amine compound which has a potent inhibitory effect on the binding of .alpha.2C-adrenoceptor and is useful in preventing and treating disorders attributable to .alpha.2C-adrenoceptor.The above-described object is solved by the
7544690 MCH receptor antagonists June 9, 2009
The present invention relates to novel compounds of the formula (I) which act as MCH receptor antagonists. These compositions are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of obesity, obesity related disorders, anxiety, or depression.
7528124 1,3-dihydro-2H-indol-2-one derivative May 5, 2009
A 1,3-dihydro-2H-indol-2-one derivative expressed by Formula 1 (wherein R.sub.1 is a halogen atom, a C.sub.1 to C.sub.4 alkyl group, etc., and R.sub.2 is a hydrogen atom, a halogen atom, etc., or R.sub.2 is in the 6-position of the indol-2-one and R.sub.1 and R.sub.2 join together to
5952715 Chip type electronic part September 14, 1999
A chip type electronic part of the present invention includes tapered notches rising from the bottom of the body of a molding. With this configuration, the electronic part achieves a high volume efficiency and a great bonding strength to a circuit board after soldering.
5597921 Indolo[2,3-b]quinoxaline derivatives January 28, 1997
Indolo[2,3-b]quinoxaline derivatives represented by the following formula: ##STR1## wherein one of R.sup.1 and R.sup.2 is a hydrogen atom and the other is a group of the formula:etc, and R.sup.3 is a hydrogen atom, a methyl group, etc.; and pharmaceutically acceptable salts thereof h
5576927 Electrolytic chip capacitor November 19, 1996
A solid electrolytic chip capacitor in which L-shaped portions of the anode terminal and cathode terminal form slanting surfaces which project beyond the projecting side surfaces of the resin sheathing.
5495046 Alkoxyphenylalkylamine derivatives February 27, 1996
An alkoxyphenylalkylamine derivative represented by the following formula: ##STR1## (wherein X.sup.1 and X.sup.2 may be either the same or different from each other and each represents a hydrogen atom, a halogen atom, a hydroxyl group, an alkoxy group having 1 to 5 carbon atoms or an










 
 
  Recently Added Patents
Method and system for fail-safe call survival
Subscribing to content
Maize variety hybrid X13A495
System and method of automatic piloting for in-flight refuelling of aircraft, and aircraft comprising said system
Switchgear operating apparatus and three-phase switchgear
Terminal device and image printing method
Liquid crystal display and method of driving the same
  Randomly Featured Patents
Gas turbine fuel injector with a rich catalyst
Router and methods using network addresses for virtualization
Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
Weather-strip for automobile
Camera with actuator for opening closed door and retracting sprocket wheel from film engageable position
Integrated conductor magnetic recording head and suspension having cross-over integrated circuits for noise reduction
Floating gate FET with hydrogen barrier shield
Method and exposure apparatus for performing a tilted focus and a device manufactured accordingly
Apparatus for inducing bloodlessness at the extremities of a patient